Multi centers, open-trial phase II study evaluating 5-azacytidine [azacitidine] (Vidaza) + valproic acid (Depakine) before administration of retinoic acid [tretinoin] (Vesanoid) in patients with acute myelogenous leukemia and high risk myelodysplasia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Azacitidine; Tretinoin; Valproic acid
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 09 May 2011 Biomarkers information updated
- 06 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2011 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.